ArticleHuman gene therapy2013

Long-term follow-up assessment of a phase 1 trial of angiogenic gene therapy using direct intramyocardial administration of an adenoviral vector expressing the VEGF121 cDNA for the treatment of diffuse coronary artery disease.

Todd K Rosengart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.